Industry
Probiotics: 2019 will be crucial for scientific and regulatory aspects with help coming also from Venture Capital. Denise Kelly from Seventure talks about it.
The development of probiotics presents major regulatory challenges. We discussed it this Clara Desvignes from Voisin Consulting Life Sciences.
New technologies such as the analysis of the "aquatic microbiota" allow to dig deeply into the microbiome chemistry. We discuss this approach with Ross Youngs, CEO of Biosortia.
